NCT07514065 2026-04-07TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyTasly Pharmaceutical Group Co., LtdPhase 1 Recruiting78 enrolled
NCT03643107 2025-01-23Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Allarity TherapeuticsPhase 2 Completed15 enrolled